CONDITION GUIDE · DC 6604

COPD: understand the requirements.

Read the clinical findings used to evaluate COPD, then compare them with the VA rating criteria under DC 6604.

What establishes the diagnosis?

Chronic obstructive pulmonary disease

Partial diagnostic criteria

COPD only; asthma and other lung conditions require their own frameworks.

GOLD 2026 strategy report and NHLBI

Clinical evaluation

Symptoms and exposure risks guide evaluation for chronic airflow disease.

Chronic obstructive pulmonary disease — source ↗ · Lung function tests; Other tests
Global Strategy for Prevention, Diagnosis and Management of COPD ↗ · Chapter 2, Spirometry and Diagnostic criterion for airflow obstruction, pp. 28–31 · Chapter 2, Differential diagnosis of COPD · Chapter 2, Initial assessment: airflow obstruction, symptoms and exacerbation history

Assessment methods

Spirometry is the principal test; imaging and blood-gas testing may address additional clinical questions.

Chronic obstructive pulmonary disease — source ↗ · Lung function tests; Other tests
Global Strategy for Prevention, Diagnosis and Management of COPD ↗ · Chapter 2, Spirometry and Diagnostic criterion for airflow obstruction, pp. 28–31 · Chapter 2, Differential diagnosis of COPD · Chapter 2, Initial assessment: airflow obstruction, symptoms and exacerbation history

Interpretation and scope

No single symptom or imaging abnormality is substituted for the clinical and physiological evaluation.

Chronic obstructive pulmonary disease — source ↗ · Lung function tests; Other tests
Global Strategy for Prevention, Diagnosis and Management of COPD ↗ · Chapter 2, Spirometry and Diagnostic criterion for airflow obstruction, pp. 28–31 · Chapter 2, Differential diagnosis of COPD · Chapter 2, Initial assessment: airflow obstruction, symptoms and exacerbation history

Confirming persistent obstruction

In someone with compatible symptoms or exposures, measure FEV1 and FVC after a bronchodilator. A ratio below 0.70 supports persistent obstruction. Record acceptable, repeatable efforts and consider alternative causes before attributing obstruction to COPD.

Global Strategy for Prevention, Diagnosis and Management of COPD ↗ · Chapter 2, Spirometry and Diagnostic criterion for airflow obstruction, pp. 28–31

Results near the cutoff

Repeat spirometry on another occasion when the post-bronchodilator ratio is between 0.60 and 0.80. Biological variation can move the result across the cutoff. The fixed ratio can classify more older adults and fewer younger adults as obstructed than age-adjusted reference limits.

Global Strategy for Prevention, Diagnosis and Management of COPD ↗ · Chapter 2, Spirometry and Diagnostic criterion for airflow obstruction, pp. 28–31

Interpreting tests during treatment

Record usual inhalers, last doses and whether the test is for confirmation or follow-up. For monitoring established COPD, GOLD allows regular bronchodilators to continue. Use the post-bronchodilator ratio for diagnostic confirmation. The size of the immediate response alone cannot distinguish asthma from COPD.

Global Strategy for Prevention, Diagnosis and Management of COPD ↗ · Chapter 2, Spirometry, considerations when performing spirometry · Chapter 2, Spirometry and Diagnostic criterion for airflow obstruction, pp. 28–31

Other causes of breathlessness and cough

Consider asthma when symptoms vary markedly. Signs of congestion warrant evaluation for heart failure. Recurrent infection and copious sputum raise bronchiectasis as a possibility. Examination, imaging and history guide investigation, including for coexisting conditions.

How COPD affects the person

After confirmation, document FEV1 percent predicted, breathlessness during activities, overall symptom burden, and exacerbations or admissions in the past year. These describe different aspects of COPD and guide follow-up.

Global Strategy for Prevention, Diagnosis and Management of COPD ↗ · Chapter 2, Initial assessment: airflow obstruction, symptoms and exacerbation history

COPD patterns

Persistent productive cough for at least three months in each of two successive years supports chronic bronchitis after other causes are considered. CT can characterize emphysema and identify coexisting bronchiectasis. When symptoms and spirometry disagree, lung volumes, gas transfer or exercise testing can clarify the source of limitation.

Global Strategy for Prevention, Diagnosis and Management of COPD ↗ · Chapters 1–2, Chronic bronchitis, Imaging and Additional investigations

Inherited and inflammatory traits

GOLD recommends testing people with COPD for alpha-1 antitrypsin deficiency, including older adults. Blood eosinophils help estimate the likely preventive benefit of inhaled corticosteroids alongside exacerbation history. A count alone cannot identify the cause of an individual flare.

Global Strategy for Prevention, Diagnosis and Management of COPD ↗ · Chapter 2, Blood eosinophil count and Alpha-1 antitrypsin deficiency

Causes of a flare

Compare the event with baseline. Worsening breathlessness, cough or sputum over up to 14 days supports an exacerbation. Infection and pollution are common triggers. Pneumonia, pulmonary embolism, heart failure and pneumothorax can resemble or accompany a flare. Record the evidence for each plausible contributor and any uncertainty about the cause.

Global Strategy for Prevention, Diagnosis and Management of COPD ↗ · Chapter 4, Definition and diagnosis, Figures 4.2–4.3

Evaluating a flare

Assess oxygenation, respiratory and heart rates, mental status and work of breathing. Select tests from the presentation: chest imaging for consolidation or pneumothorax, ECG and cardiac testing for suspected cardiac disease, and a probability-based embolism work-up when indicated. The examining clinician determines urgency and attribution.

Global Strategy for Prevention, Diagnosis and Management of COPD ↗ · Chapter 4, Definition and diagnosis, Figures 4.2–4.3
Related VA rules and distinctions

Clinical COPD assessment and VA evaluation

GOLD symptom burden and exacerbation history guide clinical care. VA evaluates COPD under DC 6604 using the listed lung-function measures or specified clinical findings. Section 4.96(d) sets testing exceptions and directs the use of post-bronchodilator values unless poorer than the pre-test results. When different measures imply different evaluations, the examiner identifies the measure that best reflects disability. A GOLD stage or symptom score alone supplies no VA percentage.

38 CFR § 4.96 ↗ · (d)(1)–(7)
38 CFR § 4.97 ↗ · Diagnostic code 6604

Scope of this clinical reference

  • Imaging, laboratory findings and competing causes require individual interpretation. An event with multiple plausible causes can remain clinically indeterminate.
Chronic obstructive pulmonary disease — source ↗ · Lung function tests; Other tests
Global Strategy for Prevention, Diagnosis and Management of COPD ↗ · Chapter 2, Spirometry and Diagnostic criterion for airflow obstruction, pp. 28–31 · Chapter 2, Differential diagnosis of COPD · Chapter 2, Initial assessment: airflow obstruction, symptoms and exacerbation history · Chapters 1–2, Chronic bronchitis, Imaging and Additional investigations · Chapter 2, Blood eosinophil count and Alpha-1 antitrypsin deficiency · Chapter 4, Definition and diagnosis, Figures 4.2–4.3

How is it connected to service?

The applicable direct, secondary, aggravation or presumptive route determines the service-connection evidence. Use the evidence guide to distinguish these routes.

Explore service-connection evidence →

What do the rating levels describe?

A diagnosis does not automatically establish a percentage. These are the source requirements for evaluating severity; related notes and exceptions still apply.

0%

A 0% evaluation may apply when the requirements for a compensable rating are not met, under §4.31.

    10%

    The 10% criteria use these alternative pulmonary-function thresholds.

    • FEV-1 at 71–80% of the predicted value.
    • FEV-1/FVC ratio at 71–80%.
    • DLCO (SB) at 66–80% of the predicted value.

    30%

    COPD uses test-based thresholds at this level. It does not share asthma’s inhaled-medication route.

    • FEV-1 at 56–70% of the predicted value.
    • FEV-1/FVC ratio at 56–70%.
    • DLCO (SB) at 56–65% of the predicted value.

    60%

    The 60% criteria use pulmonary-function or oxygen-consumption thresholds.

    • FEV-1 at 40–55% predicted, or FEV-1/FVC at 40–55%.
    • DLCO (SB) at 40–55% predicted.
    • Maximum oxygen consumption of 15–20 ml/kg/min, with a cardiorespiratory limit.

    100%

    The 100% criteria include these routes and several named heart or pulmonary complications; the full rule lists each alternative.

    • FEV-1, FEV-1/FVC, or DLCO (SB) below 40%, using the rule’s specified measures.
    • A requirement for outpatient oxygen therapy, or episodes of acute respiratory failure.
    • Maximum exercise capacity below 15 ml/kg/min oxygen consumption with cardiac or respiratory limitation.
    Compare these levels with the original rating table

    Find DC 6604 in the rating schedule

    The highlighted row marks this code. Nearby rows provide context and can describe other conditions. Use the full schedule for applicable headings, footnotes and exceptions.

    38 CFR Part 4 · excerpt surrounding DC 6604
    Rating
    FEV-1 of 56- to 70-percent predicted, or; FEV-1/FVC of 56 to 70 percent, or; DLCO (SB) 56- to 65-percent predicted30
    FEV-1 of 71- to 80-percent predicted, or; FEV-1/FVC of 71 to 80 percent, or; DLCO (SB) 66- to 80-percent predicted10
    6604 Chronic obstructive pulmonary disease:
    FEV-1 less than 40 percent of predicted value, or; the ratio of Forced Expiratory Volume in one second to Forced Vital Capacity (FEV-1/FVC) less than 40 percent, or; Diffusion Capacity of the Lung for Carbon Monoxide by the Single Breath Method (DLCO (SB)) less than 40-percent predicted, or; maximum exercise capacity less than 15 ml/kg/min oxygen consumption (with cardiac or respiratory limitation), or; cor pulmonale (right heart failure), or; right ventricular hypertrophy, or; pulmonary hypertension (shown by Echo or cardiac catheterization), or; episode(s) of acute respiratory failure, or; requires outpatient oxygen therapy.100
    FEV-1 of 40- to 55-percent predicted, or; FEV-1/FVC of 40 to 55 percent, or; DLCO (SB) of 40- to 55-percent predicted, or; maximum oxygen consumption of 15 to 20 ml/kg/min (with cardiorespiratory limit)60
    FEV-1 of 56- to 70-percent predicted, or; FEV-1/FVC of 56 to 70 percent, or; DLCO (SB) 56- to 65-percent predicted30
    FEV-1 of 71- to 80-percent predicted, or; FEV-1/FVC of 71 to 80 percent, or; DLCO (SB) 66- to 80-percent predicted10
    DISEASES OF THE LUNGS AND PLEURA—TUBERCULOSIS
    Ratings for Pulmonary Tuberculosis Entitled on August 19, 1968

    How VA handles coexisting respiratory conditions

    When more than one listed respiratory condition is present, check the predominant-disability rule before combining ratings. The special pulmonary-function-test provisions apply only to the codes listed in subsection (d).

    Read 38 CFR §4.96 ↗

    Official rating schedule · DC 6604, §4.97 ↗

    What can professional assessments clarify?

    Spirometry-centered respiratory evaluation

    Spirometry is the principal test; imaging and blood-gas testing may address additional clinical questions.

    The role depends on the condition and clinical pathway below; this is not a universal VA claim requirement.

    Spirometry with bronchodilator assessment

    Expiratory airflow and change after bronchodilator

    The role depends on the condition and clinical pathway below; this is not a universal VA claim requirement.

    COPD symptom and exacerbation assessment

    Activity-related breathlessness, daily respiratory symptoms and exacerbation history

    The role depends on the condition and clinical pathway below; this is not a universal VA claim requirement.

    A test score alone does not establish a VA percentage or service connection.

    Which evidence addresses the questions?

    • Diagnosis and history: Records identifying the current diagnosis, onset, course, and relevant medical history.
    • Diagnostic tests and measurements: Condition-relevant tests, imaging, laboratory results, and objective measurements.
    • Functional impact: Medical and lay evidence describing work and daily-activity effects.
    • Service connection evidence: Evidence addressing an in-service event, exposure, disease, injury, continuity, or a secondary relationship.
    Find evidence in the Respiratory Conditions (other than tuberculosis and sleep apnea) questionnaire

    Use these section names and page numbers to locate the examiner’s findings. Some sections apply only to particular diagnoses within this family.

    • diagnosis · p. 1, 2
    • medical history · p. 3, 4
    • pulmonary conditions · p. 4, 5, 6, 7, 8, 9
    • diagnostic testing · p. 9, 10, 11
    • functional impact · p. 11
    • remarks · p. 11
    Read the official Respiratory Conditions (other than tuberculosis and sleep apnea) questionnaire ↗

    Shared library and examination references

    How an independent medical review works →

    Sources and scope

    Clinical and evidence sources
    Chronic obstructive pulmonary disease — source ↗ · Lung function tests; Other tests
    Global Strategy for Prevention, Diagnosis and Management of COPD ↗ · Chapter 2, Spirometry and Diagnostic criterion for airflow obstruction, pp. 28–31 · Chapter 2, Differential diagnosis of COPD · Chapter 2, Initial assessment: airflow obstruction, symptoms and exacerbation history · Chapters 1–2, Chronic bronchitis, Imaging and Additional investigations · Chapter 2, Blood eosinophil count and Alpha-1 antitrypsin deficiency · Chapter 4, Definition and diagnosis, Figures 4.2–4.3

    Guide source check: 2026-11-06. Rating-library snapshot: June 30, 2026. Source coverage is distinct from clinical review. This page does not diagnose, adjudicate a claim, or collect medical records.

    Shared reference edition 1.2.4 · source check 2026-11-06. Coverage is stated for each framework and is distinct from clinical review. Rating-source snapshot: 2026-06-30.

    About these educational tools

    The calculator and guides provide general education, not medical, legal, or financial advice. Using them does not create a clinician-patient, evaluator-evaluee, or attorney-client relationship. Professional services require a separate accepted engagement.

    VA determines eligibility, service connection, ratings, qualifying dependents, effective dates, and the amount payable. Using these tools does not submit a claim or appeal.

    Diagnosis, connection to service, and severity are separate questions. Matching a description or screening score does not establish a diagnosis or entitlement. A qualified clinician should interpret medical findings. Do not change treatment based on these guides.

    Ingleside Health is an independent physician service, not a law firm or VA-accredited claims representative. It is not affiliated with or endorsed by VA and does not prepare, present, prosecute, or file benefits claims.

    Do not rely on an estimate alone for financial commitments or claim decisions. Check official VA information and seek appropriate individual advice.

    Calculation assumptions and exclusions
    • Basic compensation estimate. Special Monthly Compensation (SMC), Total Disability based on Individual Unemployability (TDIU), offsets or recoupment, back pay, temporary total ratings, and unsupported adult-dependent categories are not calculated.
    • Bilateral handling covers the supported arm/leg selections. Other paired skeletal muscles, amputation limits, and overlapping manifestations need individual review. The tool cannot determine whether every entered rating may be separately combined.
    • Use separately established evaluations or clearly hypothetical percentages. Choosing a condition or percentage does not establish diagnosis, service connection, or entitlement.
    • Uses 2026 compensation rates effective December 1, 2025. Historical payments, future rate changes, and individual effective dates are not calculated. See the source dates on each reference; rules and rates may change.
    Using the website or a chat tool

    Calculator selections stay in this browser tab's memory and are not saved or submitted as intake. Refreshing the page resets the example. Do not enter personal records or identifiers. Website visits remain subject to the Website Privacy Policy.

    Use hypothetical scenarios only in chat tools. Do not send records, identifiers, symptoms, or real case information. The chat provider's own terms and privacy settings apply; a chat conversation is not the Box-hosted clinical intake.

    Accredited Veterans Service Organization (VSO) representatives provide free help with VA benefit claims. Find VA-accredited help. Read VA’s official rating guidance.

    Terms of UseWebsite Privacy PolicyAccessibility and help

    This business is not endorsed or sponsored by, or affiliated with, the United States Department of Veterans Affairs or the Illinois Department of Veterans Affairs, or any federally chartered VA accredited veteran service organization. You may qualify for other veterans benefits beyond the benefits for which you are receiving services here.

    Veteran and military benefits services are available free of charge from VA accredited county veteran service officers, representatives of the Illinois Department of Veterans Affairs, and the veteran service officers of federally chartered veteran service organizations. To learn more, contact these organizations or the Illinois Attorney General's Office at 1-800-382-3000.